secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001217234-25-000062
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q3 revenue $100.1M (+21% YoY), turns to GAAP net income $1.7M; raises FY guidance
--------------------------------------------------------------------------------

- Revenue $100.1M, up 21% YoY; testing services volume ~50,300 (+13% YoY).
- GAAP net income $1.7M vs loss $10.6M in Q3 2024; adjusted EBITDA $15.3M vs $6.9M.
- Raised FY 2025 revenue guidance to $372M-$376M (from $367M-$373M); raised adj. EBITDA guidance to $35M-$39M.
- Cash $194.2M, no debt; repurchased $25.6M shares during quarter.
- Appointed new CMO Jeff Teuteberg, MD and board member Suresh Gunasekaran.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000062/0001217234-25-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723425000062/cdna-20251104.htm
  HTML page:      https://secwatch.observer/filing/0001217234-25-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer